Literature DB >> 28054113

[Chronic subdural hematoma in the elderly].

T A Juratli1, J Klein2, G Schackert2.   

Abstract

Chronic subdural hematoma (cSDH) is a common condition, the frequency of which further increases due to an aging population and more frequent use of antithrombotic drugs. It leads to unspecific symptoms and neurological deficits and is usually treated surgically. Burr hole trepanation and twist drill craniostomy have become the therapeutic standards with craniotomy being rarely used for recurrent cases. Although recurrences are relatively common, in most cases a good outcome can be achieved even in the elderly; however, as cSDH is associated with other comorbidities, it is indicative of an increased morbidity and mortality. Controlled trials need to be carried out to determine whether pharmacological therapies can also be beneficial in addition to surgical treatment.

Entities:  

Keywords:  Anticoagulants; Bleeding; Craniotomy; Geriatrics; Trepanation

Mesh:

Substances:

Year:  2017        PMID: 28054113     DOI: 10.1007/s00104-016-0343-6

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  38 in total

1.  Complications of burr-hole craniostomy and closed-system drainage for chronic subdural hematomas: a retrospective analysis of 376 patients.

Authors:  Veit Rohde; G Graf; W Hassler
Journal:  Neurosurg Rev       Date:  2002-03       Impact factor: 3.042

2.  Long-term survival after chronic subdural haematoma.

Authors:  Appukutty Manickam; Laurence A G Marshman; Ross Johnston
Journal:  J Clin Neurosci       Date:  2016-07-25       Impact factor: 1.961

3.  Effect of atorvastatin on resolution of chronic subdural hematoma: a prospective observational study [RETRACTED].

Authors:  Hua Liu; Zhongkun Liu; Yong Liu; Shifeng Kan; Jian Yang; Hongyi Liu
Journal:  J Neurosurg       Date:  2016-07-29       Impact factor: 5.115

4.  Chronic subdural haematoma: a review of 114 cases.

Authors:  M M Cameron
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-09       Impact factor: 10.154

5.  Increased concentration of vascular endothelial growth factor (VEGF) in chronic subdural hematoma.

Authors:  K Suzuki; S Takano; T Nose; M Doi; N Ohashi
Journal:  J Trauma       Date:  1999-03

6.  Does Early Resumption of Low-Dose Aspirin After Evacuation of Chronic Subdural Hematoma With Burr-Hole Drainage Lead to Higher Recurrence Rates?

Authors:  Maria Kamenova; Katharina Lutz; Sabine Schaedelin; Javier Fandino; Luigi Mariani; Jehuda Soleman
Journal:  Neurosurgery       Date:  2016-11       Impact factor: 4.654

Review 7.  Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients.

Authors:  Saleh A Almenawer; Forough Farrokhyar; Chris Hong; Waleed Alhazzani; Branavan Manoranjan; Blake Yarascavitch; Parnian Arjmand; Benedicto Baronia; Kesava Reddy; Naresh Murty; Sheila Singh
Journal:  Ann Surg       Date:  2014-03       Impact factor: 12.969

Review 8.  External drains versus no drains after burr-hole evacuation for the treatment of chronic subdural haematoma in adults.

Authors:  Deqing Peng; Yongjian Zhu
Journal:  Cochrane Database Syst Rev       Date:  2016-08-31

9.  Epilepsy in chronic subdural haematoma.

Authors:  Z Kotwica; J Brzeiński
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

10.  Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study.

Authors:  Daipayan Guha; Shona Coyne; R Loch Macdonald
Journal:  J Neurosurg       Date:  2015-09-11       Impact factor: 5.115

View more
  1 in total

1.  Middle Meningeal Artery Embolization Minimizes Burdensome Recurrence Rates After Newly Diagnosed Chronic Subdural Hematoma Evacuation (MEMBRANE): study protocol for a randomized controlled trial.

Authors:  Alexander Hoenning; Johannes Lemcke; Sergej Rot; Dirk Stengel; Berthold Hoppe; Kristina Zappel; Patrick Schuss; Sven Mutze; Leonie Goelz
Journal:  Trials       Date:  2022-08-22       Impact factor: 2.728

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.